Clinical Trial Update: Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Prevent Rejection in Heart Transplant Children [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial is evaluating thymic tissue-derived regulatory T cells (thyTreg) to prevent rejection in pediatric heart transplant patients and is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplantation

Drugs mentioned

• thyTreg (thymic tissue-derived regulatory T cells)

Snippet

Sponsor: Rafael Correa-Rocha | Conditions: Heart Transplantation | Phase 1, Phase 2 | Status: RECRUITING